PRAXIS PRECISION MEDICINES, INC. Temporary Equity, Dividends, Adjustment
PRAXIS PRECISION MEDICINES, INC. (PRAX) reported Temporary Equity, Dividends, Adjustment of $0 for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:TemporaryEquityDividendsAdjustment · last filed 2021-11-03
- PRAXIS PRECISION MEDICINES, INC. temporary equity, dividends, adjustment for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- PRAXIS PRECISION MEDICINES, INC. temporary equity, dividends, adjustment for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- PRAXIS PRECISION MEDICINES, INC. temporary equity, dividends, adjustment for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- PRAXIS PRECISION MEDICINES, INC. temporary equity, dividends, adjustment for the quarter ending 2020-09-30 was $3.94M, a 211.21% increase year-over-year.
| Period end | Temporary Equity, Dividends, Adjustment 3 month | Temporary Equity, Dividends, Adjustment 6 month | Temporary Equity, Dividends, Adjustment 9 month |
|---|---|---|---|
| 2021-09-30 | $0.00 10-Q · filed 2021-11-03 | $0.00 derived: sum of 2 quarters · filed 2021-11-03 | $0.00 10-Q · filed 2021-11-03 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-11 | ||
| 2020-09-30 | $3.94M 10-Q · filed 2021-11-03 | $5.98M derived: sum of 2 quarters · filed 2021-11-03 | $8.05M 10-Q · filed 2021-11-03 |
| 2020-06-30 | $2.04M 10-Q · filed 2021-08-16 | $4.10M 10-Q · filed 2021-08-16 | |
| 2020-03-31 | $2.06M 10-Q · filed 2021-05-11 | ||
| 2019-09-30 | $1.27M 10-Q · filed 2020-11-23 | $3.45M 10-Q · filed 2020-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |